Stocks That Hit 52-Week Lows On Thursday
AlloVir Appoints Diana M. Brainard, M.D., As Chief Executive Officer, Effective May 17, 2021 >ALVR
ElevateBio raises $525 million in funding from SoftBank, others
AlloVir to Present at the 10th Annual SVB Leerink Global Healthcare Conference
BRIEF-AlloVir Reports Full Year 2020 Financial Results
AlloVir FY20 EPS $(2.59) vs $(18.54) In FY19
Press Release: AlloVir Reports Full Year 2020 -2-
AlloVir shares are trading higher. Not seeing any company-specific news to justify the price action.
AlloVir to Present at the 39thAnnual J.P. Morgan Healthcare Conference
The Daily Biotech Pulse: Supernus Issues Positive ADHD Readout, Sorrento Files For Emergency Use Authorization For Rapid COVID-19 Test, Inhibikase To Make Wall Street Debut